Chemd 2025
summarizeSummary
Chemd Corporation 2025 , 4.1% $2.53 , VITAS . 12.2% $265.2 million, $18.34 $19.89 2024 . $50.3 million Medicare , Administrative Law Judge , $428 million . VITAS $27.2 million Medicare 2025 $8.4 million 2024 , . October 2025 PHI , $500,000 , . $404.5 million ,
check_boxKey Events
-
2025
4.1% $2.53 billion, 12.2% $265.2 million, $18.34 $19.89 2024 .
-
Medicare
VITAS $50.3 million Medicare , Administrative Law Judge , 2025 4 .
-
Significant Share Repurchase Program
$428.035 million (932,500 ), $127.3 million 2011 2 .
-
Medicare
VITAS $27.161 million Medicare 2025 $8.414 million 2024 , .
auto_awesomeAnalysis
Chemd Corporation 2025 , 4.1% $2.53 , VITAS . 12.2% $265.2 million, $18.34 $19.89 2024 . $50.3 million Medicare , Administrative Law Judge , $428 million . VITAS $27.2 million Medicare 2025 $8.4 million 2024 , . October 2025 PHI , $500,000 , . $404.5 million ,
在该文件披露时，CHE的交易价格为$396.05，交易所为NYSE，所属行业为Industrial Applications And Services，市值约为$56.1亿。 52周交易区间为$385.00至$623.61。 这份文件被评估为中性市场情绪，重要性评分为7/10。